Precision BioSciences, Inc.
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides…
Biotechnology
US, Durham [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Precision BioSciences, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDPrecision BioSciences, Inc. can't present revenue by segment